November 28 - 30, 2019, Institute of Physiology, Prague, Czech Republic
12 European countries and EMBL have established the Euro-BioImaging interim board on 31 March 2014. The interim board is the decision-making body during the interim phase. Currently, the interim board consists of 16 members (15 countries + EMBL). Its key tasks are to decide on the legal model and governance structure, finance plan and user access policy based on the models recommended by the preparatory phase partners.
Delegates of the Czech Republic in the Euro-BioImaging Interim Board:
November 28 - 30, 2019, Institute of Physiology, Prague, Czech Republic
November 12 - 15, 2019, Institute of Physiology CAS, Prague, Czech Republic
November 11 - 13, 2019, IMCF at Biocev, Průmyslová 595, Vestec
20th November between 12.45 and 18.30 and 21st November between 08.30 and 15.00 (CET)
November 25 - 29, 2019, Institute of Molecular Genetics CAS, Prague, Czech Republic
October 24 - 25, Institute of Molecular Genetics CAS, Prague
November 19, 2019, Charles University, Faculty of Mathematics and Physics, Prague
19 - 20 November 2019, Masaryk University, Brno
8 - 9 Ctober 2019, Heidelberg, Germany
October 29 – 30, 2019, Institute of Physiology CAS